A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
David Cameron will today pledge an extra 50,000 apprenticeships using £200m in bank fines from Labour's "failed past".
Women who drink organic milk during pregnancy may be putting the brain development of their unborn babies at risk, experts claim.
Showers turning wintry across the higher ground, accompanied by a widespread frost